ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery Guidelines for the Prevention of Cancer-Associated Venous Thromboembolism in Thoracic Surgery

Thursday, March 23, 2023

Submitted by

Cameron Lind

Source

Source Name: European Journal of Cardiothoracic Surgery

Source URL: https://doi.org/10.1093/ejcts/ezac488

Author(s)

Yaron Shargall, MD, Wojtek Wiercioch, PhD, MSc, Alessandro Brunelli, MD, Sudish Murthy, MD, PhD, Wayne Hofstetter, MD, Jules Lin, MD, Hui Li, MD, PhD, Lori-Ann Linkins, MD, MSc, Marc Crowther, MD, MSc, Roger Davis, Gaetano Rocco, MD, Gian Paolo Morgano, PhD, MSc, Finn Schünemann, MD, Giovanna Muti-Schünemann, MD, James Douketis, MD, Holger J Schünemann, MD, PhD, MSc, Virginia R Litle, MD

Thoracic oncology patients are a high-risk group for venous thromboembolism (VTE). The ESTS and AATS panel reviewed the evidence using the GRADE approach and made twenty-four recommendations for VTE prophylaxis, focusing on pharmacological and mechanical methods. The certainty surrounding the evidence for VTE prevention in thoracic surgery was generally low. Conditional recommendations were made concerning parenteral anticoagulation, extended prophylaxis and VTE screening. The need for further research on preoperative thromboprophylaxis and risk stratification in extended prophylaxis was identified.